硝普钠、多巴胺、新活素三联用药治疗难治性心力衰竭的临床研究

doi:10.3969/j.issn.10073205.2018.03.004

摘要/Abstract

摘要： ［摘要］〓
〖HTH〗目的〖HTSS〗〖KG*2〗观察硝普钠、多巴胺、新活素三联用药治疗难治性心力衰竭的临床效果。
〖HTH〗方法〖HTSS〗〖KG*2〗选取难治性心力衰竭患者120例，按照随机数字表法分为A、B、C、D组各30例。4组均行常规抗心力衰竭治疗，A组在常规治疗的基础上联用硝普钠+多巴胺、B组联用新活素+硝普钠、C组联用新活素+多巴胺、D组联用硝普钠+多巴胺+新活素。观察4组治疗7 d后临床症状、体征缓解情况，治疗后首个24 h尿量，并对比血清B型脑利钠肽（brain natriuretic peptide,BNP）及心脏彩色超声改善情况。
〖HTH〗结果〖HTSS〗〖KG*2〗治疗7 d后4组临床疗效和总有效率差异均无统计学意义(P＞005)。治疗后4组BNP水平均明显低于治疗前，B、C、D组BNP水平低于A组（P＜0.05）；B、C组BNP水平下降幅度大于A组，C组BNP水平下降幅度小于B组，D组BNP水平下降幅度差值大于A、B、C组（P＜005）。治疗后4组首个24 h尿量均明显大于治疗前，D组首个24 h尿量均明显大于A、B、C组（P＜0.05）；B、C、D组首个24 h尿量增加幅度差值大于A组，D组首个24 h尿量增加幅度差值大于B、C组（P＜005）。治疗后4组左心室射血分数(left ventricular ejection fraction，LVEF)与治疗前差异无统计学意义（P＞005），左心室舒张末期内径(left ventricular enddiastolic diameter,LVEDd)明显低于治疗前（P＜005）；4组LVEF及LVEDd差异均无统计学意义（P＞005）。B组出现血压偏低2例，其余3组均无不良反应发生。
〖HTH〗结论〖HTSS〗〖KG*2〗硝普钠、多巴胺、新活素三联用药能显著改善难治性心力衰竭患者的临床症状和利尿剂抵抗，降低BNP水平，从而有利于患者康复。

关键词: 心力衰竭, 硝普钠, 多巴胺, 新活素

Abstract: ［Abstract］〓Objective〖HTSS〗〓To observe the clinical efficacy of triple combination of sodium nitroprusside, dopamine and rhBNP in the treatment of refractory heart failure.
〖HTH〗〖WTHZ〗Methods〖HTSS〗〓A total of 120 patients with refractory heart failure who were admitted in our hospital were included in the study and randomized into groups A, B, C, and D with 30 cases in each group. The patients in the four groups were given routine antiheart failure treatments. On the above basis, the patients in group A were given sodium nitroprusside+dopamine, those in group B were given rhBNP+sodium nitroprusside, those in group C were given rhBNP+dopamine, and those in group D were given sodium nitroprusside+dopamine+rhBNP. After 7day treatment, the clinical symptoms, signs remission, and the first 24 h urine volume after treatment in the four groups were observed. The serum BNP and cardiac ultrasound improvement were compared.
〖HTH〗〖WTHZ〗Results〖HTSS〗〓The comparison of the clinical efficacy and the total effective rate 7 d after treatment among the four groups was not significantly different(P＞005). BNP levels after treatment in the four groups were significantly reduced when compared with before treatment(P＜005). BNP levels in groups B, C, and D were significantly lower than those in group A(P＜005). The reduced degree of BNP level in groups B and C was significantly greater than that in group A(P＜005) . The reduced degree of BNP level in group C was significantly less than that in group B(P＜005). And the reduced degree of BNP level in group D was significantly greater than that in groups A, B, and C(P＜005). The first 24 h urine volume after treatment in the four groups was significantly increased when compared with before treatment(P＜005). The first 24 h urine volume in group D was significantly higher than that in groups A, B, and C(P＜005). The increased degree of the first 24 h urine volume in groups B, C, and D was significantly greater than that in group A(P＜005). The increased degree of the first 24 h urine volume in group D was significantly greater than that in groups B and C(P＜005). Left ventricular ejection fraction（LVEF） value after treatment in the four groups was not significantly different when compared with before treatment(P＞005). Left ventricular enddiastolic diameter（LVEDd） after treatment was significantly reduced when compared with before treatment(P＜005). The comparison of LVEF and LVEDd among the four groups was not statistically significant(P＞005). In group B, 2 cases had hypotension, and no adverse reactions occurred in other 3 groups.
〖HTH〗〖WTHZ〗Conclusion〖HTSS〗〓The triple combination of sodium nitroprusside, dopamine and rhBNP in the treatment of refractory heart failure can significantly improve the clinical symptoms and diuretic resistance, reduce BNP level, and contribute to the rehabilitation.

Key words: heart failure, nitroprusside, dopamine, rhBNP

赵东坡，冯〓倩*，孙小燕，刘〓恒，张景鑫. 硝普钠、多巴胺、新活素三联用药治疗难治性心力衰竭的临床研究[J]. 河北医科大学学报, doi: 10.3969/j.issn.10073205.2018.03.004.

ZHAO Dongpo, FENG Qian*, SUN Xiaoyan, LIU Heng, ZHANG Jingxin. Clinical study on triple combination of sodium nitroprusside, dopamine and rhBNP in the treatment of refractory heart failure#br#[J]. Journal of Hebei Medical University, doi: 10.3969/j.issn.10073205.2018.03.004.

[1]	王家琦, 刘立天（综述）, 张飞飞, 齐晓勇（审校）. 心力衰竭中心肌能量代谢的研究进展 [J]. 河北医科大学学报, 2022, 43(8): 962-965.
[2]	张文川. 铁调素/铁蛋白比值在预测维持性血液透析患者心功能的应用[J]. 河北医科大学学报, 2022, 43(5): 525-529.
[3]	王亚玲, 张杨, 郭安君, 饶明月, 张晓丹, 孟建康. 心脏永久性起搏器的不同起搏部位对植入患者心功能的影响[J]. 河北医科大学学报, 2022, 43(1): 22-25,30.
[4]	黄玲芳, 周松, 刘黎洁, 狄宁宁, 高艳周. 环磷腺苷葡胺结合磷酸肌酸钠治疗急性心肌梗死伴心力衰竭患者的效果及对CPP、sNEP表达的影响[J]. 河北医科大学学报, 2021, 42(12): 1382-1386.
[5]	张杨春, 符金娟, 蔡琳. 沙库巴曲缬沙坦钠治疗急性心肌梗死后心力衰竭效果观察[J]. 河北医科大学学报, 2021, 42(10): 1123-1127.
[6]	王亚玲，张杨，刘涛，郭安君，王梅. 螺内酯对慢性心力衰竭患者左心室功能及血清趋化素的影响[J]. 河北医科大学学报, 2020, 41(7): 749-753.
[7]	王海燕1，姜卫星2，田丽1，傅向华3. 沙库巴曲缬沙坦对急性前壁ST段抬高型心肌梗死PCI术后心力衰竭患者心功能的影响[J]. 河北医科大学学报, 2020, 41(3): 254-258,267.
[8]	吴学虹，邱朝霞. 危重症心力衰竭患者肺部感染的病原菌分布及其影响因素研究[J]. 河北医科大学学报, 2020, 41(3): 263-267.
[9]	辛秋平, 高志旭, 曲忠慧. 无创正压通气联合药物治疗急性左心衰竭的效果及对患者生物学标记物水平的影响[J]. 河北医科大学学报, 2020, 41(10): 1121-1125.
[10]	彭〓雪，王文娟，牛洁婷. 血清胎盘生长因子与老年慢性心力衰竭患者血清NTproBNP和近期预后的相关性分析[J]. 河北医科大学学报, 2019, 40(7): 768-772.
[11]	于新龙1，张永忠2，魏海青3*. 美托洛尔联合用药治疗慢性心力衰竭的效果研究#br#[J]. 河北医科大学学报, 2019, 40(4): 401-405.
[12]	鲁志科1，孙〓榕2*. 不同剂量螺内酯对缺血性心肌病心力衰竭患者心脏结构和功能的影响[J]. 河北医科大学学报, 2018, 38(9): 1002-1006.
[13]	张〓楠，王玉通，李鲲鹏，白川盟，周继梧. β受体阻滞剂卡维地洛、美托洛尔对心力衰竭大鼠体液因子及ANP、TNFα、IL6、NE的影响分析[J]. 河北医科大学学报, 2018, 38(9): 1081-1084.
[14]	葛南南（综述），汪和贵*（审校）. 脑啡肽酶抑制剂在心血管疾病中的最新研究进展#br#[J]. 河北医科大学学报, 2018, 39(2): 236-240.
[15]	马小宁，康志敏，胡晓宁，刘朝辉，王生池. 冻干重组人脑利钠肽治疗心力衰竭的效果观察#br#[J]. 河北医科大学学报, 2017, 37(7): 829-831.

硝普钠、多巴胺、新活素三联用药治疗难治性心力衰竭的临床研究

Clinical study on triple combination of sodium nitroprusside, dopamine and rhBNP in the treatment of refractory heart failure#br#

HTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价